ExactCare Medication Management Program Proven to Reduce Average Total Cost of Care by 5 Percent for Patients with Complex Medical Needs

Ads

You May Also Like

Hemispherx Biopharma Repurposes Ampligen in Immuno-Oncology

PHILADELPHIA, May 31, 2017 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) ("Hemispherx" or the ...